FDA Approves Ferring Pharmaceuticals’ Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer
-Ferring Pharmaceuticals, USA today received approval from the U.S. Food and Drug Administration (FDA) for degarelix…
Committee for Medicinal Products for Human Use (CHMP) recommends granting marketing authorisation for FIRMAGON® (degarelix) for treatment of prostate cancer
-Ferring Pharmaceuticals received today notification that the Committee…
Ferring and Conaris complete license agreement for new recombinant molecule in gastroenterology
-Ferring Pharmaceuticals and Conaris Research Institute AG today announced that they have completed…
Ferring signs distribution agreement with BioGaia in Ireland and the Middle East
-BioGaia has extended its collaboration with the Swiss biopharmaceutical company Ferring Pharmaceuticals giving Ferring exclusive rights to sell BioGaia’s Probiotic Drops in Ireland and…
Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim® in Europe with Ferring Pharmaceuticals
-Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) and Ferring International S.A. today announced…
Archives Press release 2008
Archives Press release 2008